Skip to main content
. 2021 Jul 16;39(35):4988–5001. doi: 10.1016/j.vaccine.2021.07.034

Table 1.

Optimisation of SARS-CoV-2 S protein yields by alteration of the sequence construct.

Spike Construct Gag total amount (mg) SARS-CoV-2 S total amount (mg S to Gag ratio (%) Particle number/mL
Native (S) 23 0.16 0.7 4.37 × 1011
Native-VSV-G (SG) 19 0.5 2.63 4.37 × 1011
Prefusion (SP) 32 0.23 0.72 4.37 × 1011
Prefusion-VSV-G (SPG) 23 0.64 2.78 4.37 × 1011